Several other studies have explored the relationship between FGF-23 and the correlation with other bone markers in paediatric CKD patients [14,25-27], but they have looked at smaller and more limited population of CKD patients – for instance, advanced CKD patients [25] or renal transplant patients [27,28]. This evidence concerns the gene FGF23 and chronic kidney disease.